- Rush Medical College, Chicago, IL
Internship / Residency
- Residency, Radiation Oncology - Rush University Medical Center, Chicago, IL
- Radiation Oncology - American Board of Radiology
As Radiation Oncologist at Cancer Treatment Centers of America® (CTCA) Outpatient Care Center in Downtown Chicago, Dr. Adam Dickler is focused on seeing that he and the center’s team of cancer experts deliver the patient-centered care at the heart of the CTCA® care model. Dr. Dickler cares for his patients using sophisticated, state-of-the-art radiation therapy treatments, collaborating with a team of doctors and clinicians to deliver personalized, integrative cancer care.
Dr. Dickler is experienced in delivering targeted, individualized radiation therapies in treating many types of cancer. “Having a dedicated radiation oncology team helps facilitate appropriate and rapid management of cancer treatments,” says Dr. Dickler. “I focus on providing high-quality treatments for each of my patients. I also strive to help patients feel as comfortable as possible before, during and after their radiation treatment.”
Dr. Dickler is board certified in radiation oncology from the American Board of Radiology. He earned a Bachelor of Science degree in biology from the University of Illinois in Champaign, Illinois. He then completed a medical degree from Rush Medical College in Chicago, Illinois. His post-graduate training included a role as chief resident in the Department of Radiation Oncology at Rush University Medical Center.
Dr. Dickler previously served as assistant professor in the Department of Radiation Oncology at Rush University Medical Center. He has also authored more than 30 papers and multiple textbook chapters and has presented original research at national meetings. He has past clinical experience in emerging cancer therapies, specifically in the treatment of prostate and breast cancers.
Outside of CTCA, Dr. Dickler enjoys family time, working out and watching his beloved Chicago Cubs.
Patient ratings and comments
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.